drugset / Trial / NCT00584298

Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide

NCT00584298

Phase 1 Completed 50 enrolled Novartis
RandomizedCrossoverDouble-blind

Summary

This study is designed to provide information on feasibility and reproducibility of barostat assessments of colorectal sensory functions and compliance and their pharmacological modulation

Timeline

Start
2008-01
Primary completion
2009-04
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Octreotide Peptide